Status:
UNKNOWN
Development of an Intervention to Enhance Cancer Pain Management
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
American Cancer Society, Inc.
Conditions:
Other Cancer
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
This research study is being done to understand how patients with chronic cancer pain take their long-acting opioid medications, and to develop an intervention to enhance cancer pain management.
Detailed Description
Long-acting opioids are a common treatment for cancer pain. The purpose of this study is to develop a program for patients who are taking a prescribed long-acting opioid for their cancer pain. Partici...
Eligibility Criteria
Inclusion
- Age 21 or older
- Currently prescribed a long-acting (LA) opioid for nociceptive cancer pain (extended release oxycodone, extended-release morphine, transdermal fentanyl patches, methadone tablets)
- Ability to comprehend study materials in English
- Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2
- In charge of administering own pain medications
- Part 2 study only: within 4 months of current prescription of LA opioid for nociceptive cancer pain
Exclusion
- Impaired cognition, active substance disorder, or other active, unstable mental health disorder
- Current long-acting opioid treatment for pre-existing condition
- Part 2 study only: Prior enrollment in the Part 1 study\*\*
Key Trial Info
Start Date :
April 15 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03752268
Start Date
April 15 2014
End Date
November 30 2022
Last Update
May 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States, 02214